|
Sep 07, 2012, 11.17 AM IST
Aurobindo Pharma receives final approval from USFDA
Aurobindo Pharma has received final approvals from the US Food & Drugs Administration (USFDA) to manufacture and market Amlodipine Besylate and Benazepril Hydrochloride Capsules 2.5mg/10mg, 5mg/10mg, 5mg/10mg, 5mg/40mg, 10mg/20mg and 10mg/40mg (ANDA 202239). The products are ready to launch.Source : BSE
Read all announcements in Aurobindo Pharm
Set email alert for |
 From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'  The latest earning numbers FIRST on CNBC-TV18
News Videos
|
